1	Varón	varón	NCMS000	C0086582	hallazgo#estructura_corporal	0-5	462_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
2	de	de	SPS00	C0332285	atributo	6-8	462_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
3	58	58		-	-	9-11	462_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
4	años	año	NCMP000	C0439234	calificador	12-16	462_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
5	que	que	PR0CN000	-	-	17-20	462_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
6	acude	acudir	VMIP3S0	-	-	21-26	462_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
7	a	a	SPS00	-	-	27-28	462_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
8	control	control	NCMS000	C2587213	atributo	29-36	462_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
9	programado	programar	VMP00SM	-	-	37-47	462_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
10	de	de	SPS00	C0332285	atributo	48-50	462_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
11	una	una		C0205447_1	calificador_1	51-54	462_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
12	diabetes	diabetes	NCFN000	C0011860_1	trastorno_1	55-63	462_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-	-	-	-
13	mellitus	mellitus	AQ0CN0	C0011860_2	trastorno_2	64-72	462_QUEST_clinical_caseMIR	SENT1	I-Grp_Enfermedad	-	12	89	MultiE
14	tipo	tipo	NCMS000	C0011860_3	trastorno_3	73-77	462_QUEST_clinical_caseMIR	SENT1	B-Calificador	-	12	3845	Modif
15	2	2	Z	C0011860_4	trastorno_4	78-79	462_QUEST_clinical_caseMIR	SENT1	I-Calificador	-	14	5	MultiE
16	diagnosticada	diagnosticar	VMP00SF	-	-	80-93	462_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
17	hace	hacer	VMIP3S0	-	-	94-98	462_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
18	6	6		-	-	99-100	462_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
19	años	año	NCMP000	C0439234	calificador	101-105	462_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
20	.	.	Fp	-	-	105-106	462_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-

1	Tiene	tener	VMIP3S0	-	-	107-112	462_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
2	antecedentes	antecedente	NCMP000	-	-	113-125	462_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
3	personales	personal	AQ0CP0	-	-	126-136	462_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
4	de	de	SPS00	C0332285	atributo	137-139	462_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
5	HTA	hta	NC00YL0	-	-	140-143	462_QUEST_clinical_caseMIR	SENT2	B-Grp_Enfermedad	-	-	-	-
6	,	,	Fc	-	-	143-144	462_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
7	dislipidemia	dislipidemia	NC00SC0	C0242339	trastorno	145-157	462_QUEST_clinical_caseMIR	SENT2	B-Grp_Enfermedad	-	-	-	-
8	,	,	Fc	-	-	157-158	462_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
9	cardiopatía	cardiopatía	NCFS000	C0002962#C0151744_1	trastorno_1	159-170	462_QUEST_clinical_caseMIR	SENT2	B-Grp_Enfermedad	-	-	-	-
10	isquémica	isquémico	AQ0FS0	C0002962#C0151744_2	trastorno_2	171-180	462_QUEST_clinical_caseMIR	SENT2	B-Calificador	-	9	3846	Modif
11	y	y	CC	C1706368	calificador	181-182	462_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
12	pancreatitis	pancreatitis	NCFN000	C0030305	trastorno	183-195	462_QUEST_clinical_caseMIR	SENT2	B-Grp_Enfermedad	-	-	-	-
13	de	de	SPS00	C0332285	atributo	196-198	462_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
14	origen	origen	NCMS000	C0439659	atributo	199-205	462_QUEST_clinical_caseMIR	SENT2	B-Grp_Enfermedad	-	12	3846	Causada_por
15	biliar	biliar	AQ0CS0	-	-	206-212	462_QUEST_clinical_caseMIR	SENT2	I-Grp_Enfermedad	-	14	5	MultiE
16	.	.	Fp	-	-	212-213	462_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-

1	Su	su	DP3CS0	-	-	214-216	462_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
2	medicación	medicación	NCFS000	C0013227	sustancia	217-227	462_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
3	incluye	incluir	VMIP3S0	-	-	228-235	462_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
4	lisinopril	lisinopril	NC00SC0	C0065374	producto#sustancia	236-246	462_QUEST_clinical_caseMIR	SENT3	B-Grp_Medicamento	-	-	-	-
5	,	,	Fc	-	-	246-247	462_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
6	metoprolol	metoprolol	NCMS000	C0025859	sustancia	248-258	462_QUEST_clinical_caseMIR	SENT3	B-Grp_Medicamento	-	-	-	-
7	,	,	Fc	-	-	258-259	462_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
8	metformina	metformina	NC00SC0	C0025598	producto#sustancia	260-270	462_QUEST_clinical_caseMIR	SENT3	B-Grp_Medicamento	-	-	-	-
9	,	,	Fc	-	-	270-271	462_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
10	AAS	aas	NC00SC0	C0004057	sustancia	272-275	462_QUEST_clinical_caseMIR	SENT3	B-Grp_Medicamento	-	-	-	-
11	y	y	CC	C1706368	calificador	276-277	462_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
12	atorvastatina	atorvastatina	NC00SC0	C0286651	producto#sustancia	278-291	462_QUEST_clinical_caseMIR	SENT3	B-Grp_Medicamento	-	-	-	-
13	.	.	Fp	-	-	291-292	462_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-

1	En	en	SPS00	C1720294#C0332285	calificador#atributo	293-295	462_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
2	la	el	DA0FS0	-	-	296-298	462_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
3	exploración	exploración	NCFS000	C0031809_1	procedimiento_1	299-310	462_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
4	física	físico	NCFS000	C0031809_2	procedimiento_2	311-317	462_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
5	presenta	presentar	VMIP3S0	-	-	318-326	462_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
6	tensión	tensión	NCFS000	C0005823#C1272641_1	entidad_observable_1	327-334	462_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
7	arterial	arterial	NC00SC0	C0005823#C1272641_2	entidad_observable_2	335-343	462_QUEST_clinical_caseMIR	SENT4	B-Estructura_Corporal	-	-	-	-
8	151/93	151/93	Z	-	-	344-350	462_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
9	mmHg	mmHg	NCMP000	-	-	351-355	462_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
10	,	,	Fc	-	-	355-356	462_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
11	IMC	imc	NC00SC0	C1305855	entidad_observable	357-360	462_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
12	27,1	27,1		-	-	361-365	462_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
13	kg/m2	kg/m2		-	-	366-371	462_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
14	.	.	Fp	-	-	371-372	462_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-

1	La	el	DA0FS0	-	-	373-375	462_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
2	hemoglobina	hemoglobina	NCFS000	C0019046	sustancia	376-387	462_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
3	glicada	glicada	VMP00SF	-	-	388-395	462_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
4	es	ser	VSIP3S0	-	-	396-398	462_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
5	de	de	SPS00	C0332285	atributo	399-401	462_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
6	8,3	8.3	Z	-	-	402-405	462_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
7	%	%	Ft	-	-	406-407	462_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
8	.	.	Fp	-	-	407-408	462_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-

1	¿	¿	Fia	-	-	408-409	462_QUEST_clinical_caseMIR	SENT6	-	-	-	-	-
2	Cuál	cuál	PT0CS000	-	-	409-413	462_QUEST_clinical_caseMIR	SENT6	-	-	-	-	-
3	de	de	SPS00	C0332285	atributo	414-416	462_QUEST_clinical_caseMIR	SENT6	-	-	-	-	-
4	los	el	DA0MP0	-	-	417-420	462_QUEST_clinical_caseMIR	SENT6	-	-	-	-	-
5	siguientes	siguiente	AQ0CP0	C0332282	atributo	421-431	462_QUEST_clinical_caseMIR	SENT6	-	-	-	-	-
6	es	ser	VSIP3S0	-	-	432-434	462_QUEST_clinical_caseMIR	SENT6	-	-	-	-	-
7	el	el	DA0MS0	-	-	435-437	462_QUEST_clinical_caseMIR	SENT6	-	-	-	-	-
8	tratamiento	tratamiento	NCMS000	C1273870#C0087111	procedimiento#régimen/tratamiento	438-449	462_QUEST_clinical_caseMIR	SENT6	-	-	-	-	-
9	más	más	RG	C0205172	calificador	450-453	462_QUEST_clinical_caseMIR	SENT6	-	-	-	-	-
10	adecuado	adecuar	VMP00SM	-	-	454-462	462_QUEST_clinical_caseMIR	SENT6	-	-	-	-	-
11	para	para	SPS00	C0521125	calificador	463-467	462_QUEST_clinical_caseMIR	SENT6	-	-	-	-	-
12	este	este	DD0MS0	-	-	468-472	462_QUEST_clinical_caseMIR	SENT6	-	-	-	-	-
13	paciente	paciente	NCCS000	C0030705	persona	473-481	462_QUEST_clinical_caseMIR	SENT6	-	-	-	-	-
14	?	?	Fit	-	-	481-482	462_QUEST_clinical_caseMIR	SENT6	-	-	-	-	-
15	:	:	Fd	-	-	482-483	462_QUEST_clinical_caseMIR	SENT6	-	-	-	-	-
16	.	.	Fp	-	-	483-484	462_QUEST_clinical_caseMIR	SENT6	-	-	-	-	-

